NioCorp (NB) CFO receives 114,007 employee stock options at $4.74 strike price

Rhea-AI Filing Summary

NioCorp Developments Ltd reported that Chief Financial Officer Neal S. Shah received a grant of employee stock options. The award covers 114,007 options to buy common shares at an exercise price of $4.74 per share, all held directly.

According to the vesting schedule, 34% of the options vested on the July 6, 2026 grant date, 33% will vest on the first anniversary, and the remaining balance will vest on the second anniversary on July 6, 2028. Following this grant, Shah holds 114,007 derivative securities of this option series, with an expiration date of July 6, 2031.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Shah Neal S.

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	114,007	$0.00	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 114,007 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 114,007 options Exercise price: $4.74 per share Options after grant: 114,007 derivative securities +4 more

7 metrics

Options granted 114,007 options Employee stock option grant to CFO Neal S. Shah

Exercise price $4.74 per share Strike price for the employee stock options

Options after grant 114,007 derivative securities Total options of this series held directly after transaction

Immediate vesting portion 34% of options Vested on the July 6, 2026 grant date

First anniversary vesting 33% of options Scheduled to vest on first anniversary of grant

Final vesting date July 6, 2028 Remaining balance vests on second anniversary of grant

Option expiration July 6, 2031 Expiration date of the employee stock options

Key Terms

Employee Stock Option (Right to Buy), grant/award acquisition, vested, exercise price, +1 more

5 terms

Employee Stock Option (Right to Buy) financial

"security_title: Employee Stock Option (Right to Buy)"

grant/award acquisition financial

"transaction_action: grant/award acquisition"

vested financial

"34% of the options vested on the grant date"

exercise price financial

"conversion_or_exercise_price: 4.7400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2031-07-06T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/08/2026 - 04:01 PM Accepted by SEC EDGAR 07/08/2026 - 04:01 PM Learn about SEC filing dates

FAQ

What insider transaction did NioCorp (NB) report for CFO Neal S. Shah?

NioCorp reported that CFO Neal S. Shah received a grant of 114,007 employee stock options. These options give him the right to buy common shares at a set price, structured as part of his compensation package.

How many stock options did the NioCorp (NB) CFO receive and at what price?

The CFO received 114,007 employee stock options with an exercise price of $4.74 per share. This means he can purchase NioCorp common shares at $4.74 once the options vest and before they expire.

What is the vesting schedule for the NioCorp (NB) CFO stock option grant?

The option grant vests over two years: 34% vested on the July 6, 2026 grant date, 33% will vest on the first anniversary, and the remaining balance will vest on the second anniversary, identified as July 6, 2028.

When do the NioCorp (NB) CFO stock options expire?

The employee stock options granted to the NioCorp CFO expire on July 6, 2031. He must exercise any vested options before this expiration date or they will lapse and no longer be exercisable.

Is the NioCorp (NB) CFO’s stock option grant a market purchase or a compensation award?

The transaction is a compensation-related grant, coded as a grant, award, or other acquisition. It is not an open-market purchase; the options were awarded with a $0 grant price and a $4.74 exercise price.

How many derivative securities does the NioCorp (NB) CFO hold after this grant?

Following the transaction, the CFO holds 114,007 derivative securities of this option series directly. This figure reflects the full size of the newly granted stock option award reported in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Neal S.

(Last) (First) (Middle)

C/O NIOCORP DEVELOPMENTS LTD.

7000 YOSEMITE STREET, SUITE 115

(Street)

CENTENNIAL COLORADO 80112

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NIOCORP DEVELOPMENTS LTD [ NB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$4.74	07/06/2026		A		114,007		(1)	07/06/2031	Common Shares	114,007	$0	114,007	D

Explanation of Responses:

1. 34% of the options vested on the grant date, 33% of the options will vest on the first anniversary of the grant date, and the remaining balance will vest on the second anniversary of the grant date (July 6, 2028).

	/s/ Neal S. Shah	07/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)